x

MANGOCEUTICALS, INC. (Nasdaq:MGRX)

Health Care/Life Sciences • Pharmaceuticals
CIK 1938046
Company

Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company was founded on October 7, 2021 and is headquartered in Dallas, TX.

Address
15110 North Dallas Parkway
Suite 600
Dallas, Texas 75248
Employees
3
Stock Info
Close
$4.3400
Day Range
4.0300 - 4.4900
52 Week Range
2.0700 - 16.8000
Average volume
100.77K
Short Interest
71.47K (02/14/25)
% of Float Shorted
2.97%
Market Cap
$21.22M
Revenue
$731.49K
Net Income
-$9.21M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$5.7206
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman & Chief Executive Officer
Jacob D. Cohen
President & Director
Antonios Isaac
Independent Director
Lorraine D’Alessio
Independent Director
Alex P. Hamilton
Independent Director
Kenny Myers
SEC filings
DateFormEvent
19 Dec, 2024 8-K
6 Dec, 2024 8-K
14 Nov, 2024 10-Q
12 Nov, 2024 8-K
12 Nov, 2024 4
31 Oct, 2024 8-K
25 Oct, 2024 8-K
22 Oct, 2024 8-K
21 Oct, 2024 8-K
11 Oct, 2024 8-K
3 Oct, 2024 8-K
2 Oct, 2024 8-K
1 Oct, 2024 8-K
27 Sep, 2024 8-K
5 Sep, 2024 EFFECT
3 Sep, 2024 CORRESP
30 Aug, 2024 AW
29 Aug, 2024 UPLOAD
27 Aug, 2024 SC 13D/A
27 Aug, 2024 4
23 Aug, 2024 8-K
16 Aug, 2024 S-1
15 Aug, 2024 8-K
14 Aug, 2024 10-Q
26 Jul, 2024 POS AM
11 Jul, 2024 8-K
2 Jul, 2024 8-K
27 Jun, 2024 4
24 Jun, 2024 144/A
20 Jun, 2024 144/A
18 Jun, 2024 144
18 Jun, 2024 8-K
10 Jun, 2024 144
5 Jun, 2024 8-K
5 Jun, 2024 4
5 Jun, 2024 4
5 Jun, 2024 4
5 Jun, 2024 4
5 Jun, 2024 4
5 Jun, 2024 SC 13D/A
16 May, 2024 DEF 14A
16 May, 2024 ARS
15 May, 2024 10-Q
14 May, 2024 S-8
9 May, 2024 EFFECT
7 May, 2024 CORRESP
6 May, 2024 S-1/A
6 May, 2024 PRE 14A
2 May, 2024 8-K
30 Apr, 2024 UPLOAD
25 Apr, 2024 8-K
23 Apr, 2024 S-1
11 Apr, 2024 8-K
1 Apr, 2024 10-K
26 Mar, 2024 8-K
1 Mar, 2024 DEF 14A
20 Feb, 2024 PRE 14A
25 Jan, 2024 8-K
23 Jan, 2024 8-K
2 Jan, 2024 SC 13D/A
2 Jan, 2024 8-K
29 Dec, 2023 4
19 Dec, 2023 8-K
19 Dec, 2023 EFFECT
18 Dec, 2023 POS AM
15 Dec, 2023 POS AM
14 Dec, 2023 EFFECT
12 Dec, 2023 S-1/A
11 Dec, 2023 CORRESP
11 Dec, 2023 S-1
11 Dec, 2023 8-K
11 Dec, 2023 CORRESP
11 Dec, 2023 CORRESP
11 Dec, 2023 CORRESP
30 Nov, 2023 UPLOAD
24 Nov, 2023 DRS
7 Nov, 2023 8-K
1 Nov, 2023 8-K
27 Oct, 2023 10-Q
19 Oct, 2023 8-K
4 Oct, 2023 4
4 Oct, 2023 8-K
21 Sep, 2023 8-K
8 Sep, 2023 8-K
28 Jul, 2023 10-Q
23 Jun, 2023 8-K
10 May, 2023 10-Q
4 May, 2023 3
4 May, 2023 8-K
4 May, 2023 4
3 May, 2023 SC 13D
2 May, 2023 4
18 Apr, 2023 S-8
29 Mar, 2023 SEC STAFF
22 Mar, 2023 424B4 IPO completed
22 Mar, 2023 424B4
21 Mar, 2023 CERT
21 Mar, 2023 3
20 Mar, 2023 3
20 Mar, 2023 3
20 Mar, 2023 3
20 Mar, 2023 EFFECT
20 Mar, 2023 3
20 Mar, 2023 3
17 Mar, 2023 CORRESP
17 Mar, 2023 CORRESP
17 Mar, 2023 CORRESP
17 Mar, 2023 CORRESP
14 Mar, 2023 CORRESP
14 Mar, 2023 CORRESP
28 Feb, 2023 CORRESP
28 Feb, 2023 S-1/A
24 Feb, 2023 UPLOAD
22 Feb, 2023 CORRESP
22 Feb, 2023 CORRESP
21 Feb, 2023 S-1/A
10 Feb, 2023 CORRESP
10 Feb, 2023 CORRESP
6 Feb, 2023 S-1/A
6 Feb, 2023 8-A12B
3 Feb, 2023 CORRESP
1 Feb, 2023 UPLOAD
26 Jan, 2023 S-1/A
24 Jan, 2023 SEC STAFF
13 Jan, 2023 S-1
22 Dec, 2022 DRSLTR
21 Dec, 2022 DRS/A
20 Dec, 2022 DRSLTR
9 Dec, 2022 UPLOAD
18 Nov, 2022 DRS/A
17 Nov, 2022 DRSLTR
27 Oct, 2022 UPLOAD
11 Oct, 2022 D/A
26 Sep, 2022 DRS
31 Aug, 2022 D
Last update:2025-03-06 12:33:22.281347

Sign Up to Subscribe